ID
19665
Description
A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02443467
Link
https://clinicaltrials.gov/show/NCT02443467
Keywords
Versions (1)
- 1/20/17 1/20/17 -
Uploaded on
January 20, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer, Early Breast Cancer NCT02443467
Eligibility Breast Cancer, Early Breast Cancer NCT02443467
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Left ventricular ejection fraction
Data type
boolean
Alias
- UMLS CUI [1]
- C0428772
Description
Lung disease Advanced
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0024115
- UMLS CUI [1,2]
- C0205179
Description
Dyspnea Severe
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0013404
- UMLS CUI [1,2]
- C0205082
Description
Laboratory test result abnormal
Data type
boolean
Alias
- UMLS CUI [1]
- C0438215
Description
Peripheral Neuropathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0031117
Description
CNS metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0686377
Similar models
Eligibility Breast Cancer, Early Breast Cancer NCT02443467
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0282564 (UMLS CUI [1,2])
C0332256 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])